Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis

K Farsalinos, A Barbouni, K Poulas… - … advances in chronic …, 2020 - journals.sagepub.com
Background: The purpose of this study was to examine the prevalence and effects of current
smoking on adverse outcomes among hospitalized COVID-19 patients. Methods: A …

Asthma and COVID-19: an update

Y Adir, W Saliba, A Beurnier… - European Respiratory …, 2021 - Eur Respiratory Soc
As the world faces the coronavirus disease 2019 (COVID-19) pandemic due to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, concerns have been raised …

[HTML][HTML] Risk factors for hospitalization and mortality due to COVID-19 in Espírito Santo State, Brazil

RCM Soares, LR Mattos, LM Raposo - The American journal of …, 2020 - ncbi.nlm.nih.gov
Brazil is, at the time of writing, the global epicenter of COVID-19, but information on risk
factors for hospitalization and mortality in the country is still limited. Demographic and …

Asthma-associated risk for COVID-19 development

C Skevaki, A Karsonova, A Karaulov, M Xie… - Journal of allergy and …, 2020 - Elsevier
The newly described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for a pandemic (coronavirus disease 2019 [COVID-19]). It is now well …

Clinical characteristics of 182 pediatric COVID‐19 patients with different severities and allergic status

H Du, X Dong, J Zhang, Y Cao, M Akdis, P Huang… - Allergy, 2021 - Wiley Online Library
Background The pandemic of coronavirus disease 2019 (COVID‐19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has made widespread …

Machine-learning approaches in COVID-19 survival analysis and discharge-time likelihood prediction using clinical data

M Nemati, J Ansary, N Nemati - Patterns, 2020 - cell.com
As a highly contagious respiratory disease, COVID-19 has yielded high mortality rates since
its emergence in December 2019. As the number of COVID-19 cases soars in epicenters …

Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients

L Cipollaro, L Giordano, J Padulo, F Oliva… - Journal of orthopaedic …, 2020 - Springer
The novel SARS-CoV-2 (COVID-19) became a pandemic on 11 March 2020. The
epidemiological picture is constantly evolving, and on 13 May, 4,170,424 cases and …

[HTML][HTML] Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis

BM Henry, I Cheruiyot, J Vikse, V Mutua… - Acta Bio Medica …, 2020 - ncbi.nlm.nih.gov
Background: There is a compelling need to identify clinical and laboratory predictors of
unfavorable clinical course and death in patients with coronavirus disease (COVID-19). A …

Cancer associates with risk and severe events of COVID‐19: A systematic review and meta‐analysis

Y Tian, X Qiu, C Wang, J Zhao, X Jiang… - … journal of cancer, 2021 - Wiley Online Library
Evidence is mounting to indicate that cancer patients may have more likelihood of having
coronavirus disease 2019 (COVID‐19) but lack consistency. A robust estimate is urgently …

Lymphopenia as a biological predictor of outcomes in COVID-19 patients: a nationwide cohort study

J Lee, SS Park, TY Kim, DG Lee, DW Kim - Cancers, 2021 - mdpi.com
Simple Summary The coronavirus disease 2019 (COVID-19) pandemic caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a major global …